Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2018-03-20 Board/Management Inform…
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Appointment of Dr Andrew Stephens to Advisory Board 2 pages 96.1KB
Board/Management Information Classification · 95% confidence The document is an ASX media announcement about the appointment of Dr. Andrew Stephens to Invion's advisory board. It focuses on management and advisory board changes, highlighting the expertise and collaboration benefits. There is no financial data, no report attached or referenced, and no mention of shareholder votes or capital changes. The content fits the category of Board/Management Information (MANG) as it announces a change in the company's advisory board composition.
2018-03-20 English
Invion alliance with Hudson Institute of Medical Research 2 pages 87.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX media announcement about Invion securing a research alliance with the Hudson Institute of Medical Research. It discusses the collaboration framework, research focus, and funding arrangements. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate announcement about a strategic partnership and management role change, not a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general corporate announcement about a research alliance and management update, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2018-03-19 English
Appendix 3Y - Brown 3 pages 74.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the date of change. This is a clear report of personal share transactions by a company director. There is no indication that this is a full financial report, earnings release, or any other type of corporate filing. The document fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a mere announcement or certification but a detailed notice of director's interest change.
2018-03-18 English
Appendix 3Y - Campbell 2 pages 74.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the interest, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3625 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2018-03-18 English
Appendix 3Y - Collier 3 pages 74.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the interest, and dates. This is a formal notification of a director's personal share transactions, specifically insider trades. The document does not contain financial performance data, management discussion, or other report content. It fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4146 characters, consistent with a detailed but specific insider trading notice. Therefore, the correct classification is DIRS with high confidence.
2018-03-18 English
Appendix 3Y - Chew 2 pages 74.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the date of change. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of 'Director's Dealing' filings. The document length is 3531 characters, which is consistent with a detailed notice but not a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2018-03-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.